BRAINWeek Bites -  Bringing the latest in brain health and wellness innovation.

Pediatric Migraine Nerve Blocks
“a feasible therapeutic option”

Nerve Blocking Migraine in Children

A Cureus retrospective study explored greater occipital nerve (GON) blocks for severe medically refractory headaches in patients 18 or younger. The blocks consisted of chirocaine and depomedrone in up to 3 administrations. All in the small test group, consisting of 6 patients, found relief after receiving the GON block. In addition to migraine relief, quality of life improved along with better sleep and mobility. Another plus: less risk of potential headache from medication overuse. Repeat blocks were necessary in some of the patients, and worked well.

Although the study size was small and lacked a control group, results were encouraging. The study concluded, “Chronic migraine is a debilitating condition in children with a dearth of well-established therapies, unlike in the adult population. We investigated the effects of greater occipital nerve blocks as a treatment for migraine refractory to standard medications. We found that GON block was well-tolerable and effective in all six subjects for headache burden relief and was associated with improvements in quality of life and concomitant reduction in pain medication usage.”

Explore the Summit agenda!